PharmGen Science, Inc. (KRX: 004720)

PharmGen Science Revenue

PharmGen Science had revenue of 41.65B KRW in the quarter ending September 30, 2024, with 1.22% growth. This brings the company's revenue in the last twelve months to 173.60B, up 9.08% year-over-year. In the year 2023, PharmGen Science had annual revenue of 166.78B with 10.50% growth.

• Revenue (ttm): 173.60B
• Revenue Growth: +9.08%
• P/S Ratio: 0.44
• Revenue / Employee: 683.46M
• Employees: 254
• Market Cap: 76.45B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	166.78B	15.85B	10.50%
Dec 31, 2022	150.93B	41.06B	37.38%
Dec 31, 2021	109.87B	13.25B	13.72%
Dec 31, 2020	96.61B	1.48B	1.55%
Dec 31, 2019	95.14B	6.04B	6.77%